Molecular biologist, MSc PhD FESC.
Funded by the Young Research Talent Program of the Research Council of Norway (RCN; 2017 – ).
Awarded several international and national awards, incl. Young Investigator Award (YIA) at the European Society of Cardiology (ESC; 2010, 2012, 2013) and His Majesty the King of Norway’s Gold Medal for Young Researchers (2012).
Selected/elected member of several research committees, incl. the Committee on Translational Research of the Heart Failure Ass (HFA) of the ESC (2014-2018), leader group of the Norwegian PhD School of Heart Research (NORHEART, 2013 – ), the Cardiovascular Board of Nasjonalforeningen for Folkehelsen (2018 – ) and Nucleus member of the Working Group of Myocardial Function of the ESC (2020 – ).
Research area
- Cardiomyocyte signaling
- Fibroblast signaling
- Fibrosis
- Genetic cardiology
- Heart failure
Latest publications
view all >Frisk M, Le C, Shen X, Røe ÅT, Hou Y, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tønnessen T, Jones PP, Altara R, Louch WE (2021)
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
J Am Coll Cardiol, 77 (4), 405-419
PubMed 33509397 DOI 10.1016/j.jacc.2020.11.044
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
J Am Coll Cardiol, 77 (4), 405-419
PubMed 33509397 DOI 10.1016/j.jacc.2020.11.044
Herum KM, Romaine A, Wang A, Melleby AO, Strand ME, Pacheco J, Braathen B, Dunér P, Tønnessen T, Lunde IG, Sjaastad I, Brakebusch C, McCulloch AD, Gomez MF, Carlson CR, Christensen G (2020)
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
J Am Heart Assoc, 9 (3), e013518
PubMed 32000579 DOI 10.1161/JAHA.119.013518
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
J Am Heart Assoc, 9 (3), e013518
PubMed 32000579 DOI 10.1161/JAHA.119.013518
Mohammadzadeh N, Melleby AO, Palmero S, Sjaastad I, Chakravarti S, Engebretsen KVT, Christensen G, Lunde IG, Tønnessen T (2020)
Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload
Cardiology, 145 (3), 187-198
PubMed 31968347 DOI 10.1159/000505318
Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload
Cardiology, 145 (3), 187-198
PubMed 31968347 DOI 10.1159/000505318
Tan CY, Wong JX, Chan PS, Tan H, Liao D, Chen W, Tan LW, Ackers-Johnson M, Wakimoto H, Seidman JG, Seidman CE, Lunde IG, Zhu F, Hu Q, Bian J, Wang JW, Foo RS, Jiang J (2019)
[No title available]
Circ Res, 125 (9), 834-846
PubMed 31495264 DOI 10.1161/CIRCRESAHA.119.314794
[No title available]
Circ Res, 125 (9), 834-846
PubMed 31495264 DOI 10.1161/CIRCRESAHA.119.314794
Shahini N, Ueland T, Auensen A, Michelsen AE, Ludviksen JK, Hussain AI, Pettersen KI, Aakhus S, Espeland T, Lunde IG, Kirschfink M, Nilsson PH, Mollnes TE, Gullestad L, Aukrust P, Yndestad A, Louwe MC (2019)
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis
J Immunol, 203 (7), 1973-1980
PubMed 31492744 DOI 10.4049/jimmunol.1801244
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis
J Immunol, 203 (7), 1973-1980
PubMed 31492744 DOI 10.4049/jimmunol.1801244